ESAB · NASDAQ · STOCK
ESAB
$92.09
52W $82.19 – $137.42
56/100
$5.59B
33.6
1.14
Is ESAB Bullish or Bearish?
Mixed.
Innellis AI committee rates ESAB (ESAB) Watch with a composite score of 56/100
, based on 5 analysts with 60% agreement.
Last updated August 08, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.75 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.25 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is bollinger bandwidth of 16.2% signals elevated volatility. The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.15 across 13 articles, 14d) — News
Bear Case
- 3 consecutive earnings misses -- execution concerns — Growth
- Bollinger bandwidth of 16.2% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 08, 2026
Overall Committee Score
56/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 69%
of 158 Industrials peers
Growth Analyst
neutral
52
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 3 consecutive earnings misses -- execution concerns
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 16.2% signals elevated volatility
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.15 across 13 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score strengthened from 53.0 to 56.2.
- Conviction changed from contested to moderate.
- Committee agreement increased notably from 50% to 60%.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 3 signal(s) disappeared.
- Analyst(s) abstained: Value Analyst.
Analyst-level changes:
- Growth Analyst: score 41->52 (+11).
- News Analyst: +1 bullish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Value Analyst abstained (was neutral at 48).
Comparing 2026-08-07 to 2026-08-08 (1 day apart).
Technical Analysis
RSI (14)
55.9
Neutral
MACD Histogram
1.068
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$89.69
Resistance
$103.33
Bollinger %B
0.77
Inside Bands
Price vs Moving Averages
EMA 9
$90.93
Above
EMA 21
$90.06
Above
EMA 50
$91.74
Above
EMA 200
$102.34
Below
Fundamental Analysis
Valuation
71
Growth
46
Profitability
42
Financial Health
87
Cash Flow
70
Valuation
P/E Ratio
33.6×
P/B Ratio
2.22×
PEG Ratio
-0.95
Dividend Yield
0.46%
52W High
$137.42
52W Low
$82.19
Quality & Growth
ROE
1046.9%
ROA
475.8%
Gross Margin
3568.6%
Operating Margin
1506.4%
Revenue Growth YoY
—
Debt / Equity
0.95
AI Fundamental Assessment
P/E ratio of 33.6 (rich relative to a 15-40x range); Price-to-book of 2.2x; PEG ratio of -1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.5%; Return on assets of 4.8%; Net margin of 5.7%; Gross margin of 35.7%; Current ratio of 1.96 (healthy short-term liquidity); Debt-to-equity of 0.95; Free cash flow per share is positive (3.75); Most recent quarter missed estimates by 5.3%; 3 consecutive earnings misses; EPS growth accelerating (-3.0% -> +1.5% QoQ); Average YoY EPS growth of -2.2%; Analyst estimates rising over recent quarters
Get the Full ESAB Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →